EUVIMEDEUVIMED entdecken
Crossref

The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy

Matheus Henrique Dias, Chrysa Papagianni, Rene Bernards

Cancer Cell · 2024-06 · 42 (6) · 919-922

DOI: 10.1016/j.ccell.2024.04.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2024-06. Verfasst von Matheus Henrique Dias und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Neoplasms, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Ministerie van Volksgezondheid, Welzijn en Sport, Dutch Cancer Society, Oncode Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most targeted cancer drugs inhibit the oncogenic signals to which cancer cells are addicted. We discuss here a counterintuitive approach to cancer therapy, which consists of deliberate overactivation of the oncogenic signals to overload the stress responses of cancer cells. We discuss why such overactivation of oncogenic signaling, combined with perturbation of the stress response pathways, can be potentially effective in killing cancer cells, aiming to inspire further discussion and consideration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsSignal TransductionAnimalsHumansAntineoplastic AgentsMolecular Targeted TherapyOncogenes

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: r.bernards@nki.nl.

Förderung

  • Ministerie van Volksgezondheid, Welzijn en Sport
  • Dutch Cancer Society
  • Oncode Institute

Zitieren

APA

Dias, M. H., Papagianni, C., & Bernards, R. (2024). The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy. Cancer Cell, 42(6), 919-922. https://doi.org/10.1016/j.ccell.2024.04.014

Vancouver

Dias MH, Papagianni C, Bernards R. The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy. Cancer Cell. 2024;42(6):919-922. doi:10.1016/j.ccell.2024.04.014

BibTeX
@article{Dias2024,
  author = {Dias, Matheus Henrique and Papagianni, Chrysa and Bernards, Rene},
  title = {The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy},
  journal = {Cancer Cell},
  year = {2024},
  volume = {42},
  number = {6},
  pages = {919--922},
  doi = {10.1016/j.ccell.2024.04.014}
}
Kostenlos starten →